These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21630282)

  • 21. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs.
    Nagahama K; Matsunaga Y; Kawachi M; Ito K; Tanaka T; Hori Y; Oka H; Takei M
    Neurogastroenterol Motil; 2012 Jun; 24(6):566-74, e256. PubMed ID: 22429221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo metabolite identification of acotiamide in rats using ultra-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry.
    Patel PN; Kalariya PD; Thummar M; Gananadhamu S; Srinivas R
    Biomed Chromatogr; 2017 Jul; 31(7):. PubMed ID: 27943342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Acotiamide on the Esophageal Motility Function in Patients with Esophageal Motility Disorders: A Pilot Study.
    Muta K; Ihara E; Fukaura K; Tsuchida O; Ochiai T; Nakamura K
    Digestion; 2016; 94(1):9-16. PubMed ID: 27326454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensive gastric mucosal atrophy is a possible predictor of clinical effectiveness of acotiamide in patients with functional dyspepsia
.
    Miki A; Yamamoto T; Maruyama K; Nakamura N; Aoyagi H; Isono A; Abe K; Kita H
    Int J Clin Pharmacol Ther; 2017 Dec; 55(12):901-904. PubMed ID: 29092728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of acotiamide for the treatment of functional dyspepsia.
    Sun Y; Song G; McCallum RW
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1161-8. PubMed ID: 24881488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of acotiamide on epigastric pain syndrome and postprandial distress syndrome in patients with functional dyspepsia.
    Shinozaki S; Osawa H; Sakamoto H; Hayashi Y; Kawarai Lefor A; Yamamoto H
    J Med Invest; 2016; 63(3-4):230-5. PubMed ID: 27644564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spectrofluorimetric determination of acotiamide hydrochloride trihydrate in the presence of its oxidative degradation product.
    Attia KAM; Nassar MWI; El-Olemy A; Ramzy S
    Luminescence; 2018 Jun; 33(4):806-811. PubMed ID: 29637695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing and Predictors of Recurrence of Dyspepsia Symptoms after Cessation of Acotiamide Therapy for Functional Dyspepsia: A Long-Term Observational Study.
    Shinozaki S; Osawa H; Sakamoto H; Hayashi Y; Kobayashi Y; Miura Y; Lefor AK; Yamamoto H
    Digestion; 2020; 101(4):382-390. PubMed ID: 31063995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acotiamide attenuates central urocortin 2-induced intestinal inflammatory responses, and urocortin 2 treatment reduces TNF-α productions in LPS-stimulated macrophage cell lines.
    Yamawaki H; Futagami S; Sakasegawa N; Murakami M; Agawa S; Ikeda G; Noda H; Kirita K; Gudis K; Higuchi K; Kodaka Y; Ueki N; Iwakiri K
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13813. PubMed ID: 32030855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging drugs for functional dyspepsia.
    Zala AV; Walker MM; Talley NJ
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):221-33. PubMed ID: 25645940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats.
    Seto K; Sasaki T; Katsunuma K; Kobayashi N; Tanaka K; Tack J
    Neurogastroenterol Motil; 2008 Sep; 20(9):1051-9. PubMed ID: 18482254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacological and clinical profile of acotiamide hydrochloride hydrate (Acofide(®) Tablets 100 mg), a novel therapeutic agent for functional dyspepsia (FD)].
    Matsunaga Y; Tanaka T; Saito Y; Kato H; Takei M
    Nihon Yakurigaku Zasshi; 2014 Feb; 143(2):84-94. PubMed ID: 24531902
    [No Abstract]   [Full Text] [Related]  

  • 33. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia.
    Matsueda K; Hongo M; Tack J; Saito Y; Kato H
    Gut; 2012 Jun; 61(6):821-8. PubMed ID: 22157329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of acotiamide on gastric emptying in healthy adult humans.
    Zai H; Matsueda K; Kusano M; Urita Y; Saito Y; Kato H
    Eur J Clin Invest; 2014 Dec; 44(12):1215-21. PubMed ID: 25370953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyspepsia.
    Ford AC; Moayyedi P
    Curr Opin Gastroenterol; 2013 Nov; 29(6):662-8. PubMed ID: 24100727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A long-term study of acotiamide in patients with functional dyspepsia: results from an open-label phase III trial in Japan on efficacy, safety and pattern of administration.
    Matsueda K; Hongo M; Ushijima S; Akiho H
    Digestion; 2011; 84(4):261-8. PubMed ID: 21934307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of Chaihu-Shugan-San to patients with functional dyspepsia.
    Qiu XJ; Huang X; Chen ZQ; Ren P; Huang W; Qin F; Hu SH; Huang J; He J; Liu ZQ; Zhou HH
    J Ethnopharmacol; 2011 Sep; 137(1):205-13. PubMed ID: 21605652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of acotiamide for the treatment of functional dyspepsia: systematic review and meta-analysis.
    Xiao G; Xie X; Fan J; Deng J; Tan S; Zhu Y; Guo Q; Wan C
    ScientificWorldJournal; 2014; 2014():541950. PubMed ID: 25197703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and brain distribution of tetrahydropalmatine and tetrahydroberberine after oral administration of DA-9701, a new botanical gastroprokinetic agent, in rats.
    Jung JW; Kwon YS; Jeong JS; Son M; Kang HE
    Biol Pharm Bull; 2015; 38(2):285-91. PubMed ID: 25747988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.